Evidence map›Paper›PMID 36970514›Full record

ArticleFrontiers in neurology2023

Identification of key genes and signaling pathways associated with dementia with Lewy bodies and Parkinson's disease dementia using bioinformatics.

Jing Xu, Jia Li, Ya-Juan Sun, Wei Quan, Li Liu, Qing-Hui Zhang, Yi-Dan Qin, Xiao-Chen Pei, Hang Su, Jia-Jun Chen

Open access · goldFull text read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jing XuDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Jia LiDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Ya-Juan SunDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Wei QuanDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Li LiuDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Qing-Hui ZhangDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Yi-Dan QinDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Xiao-Chen PeiDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Hang SuDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Jia-Jun ChenDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Jilin University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are collectively known as Lewy body dementia (LBD). Considering the heterogeneous nature of LBD and the different constellations of symptoms with which patients can present, the exact molecular mechanism underlying the differences between these two isoforms is still unknown. Therefore, this study aimed to explore the biomarkers and potential mechanisms that distinguish between PDD and DLB. Methods: The mRNA expression profile dataset of GSE150696 was acquired from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) between 12 DLB and 12 PDD were identified from Brodmann area 9 of human postmortem brains using GEO2R. A series of bioinformatics methods were applied to identify the potential signaling pathways involved, and a protein-protein interaction (PPI) network was constructed. Weighted gene co-expression network analysis (WGCNA) was used to further investigate the relationship between gene co-expression and different LBD subtypes. Hub genes that are strongly associated with PDD and DLB were obtained from the intersection of DEGs and selected modules by WGCNA. Results: A total of 1,864 DEGs between PDD and DLB were filtered by the online analysis tool GEO2R. We found that the most significant GO- and KEGG-enriched terms are involved in the establishment of the vesicle localization and pathways of neurodegeneration-multiple diseases. Glycerolipid metabolism and viral myocarditis were enriched in the PDD group. A B-cell receptor signaling pathway and one carbon pool by folate correlated with DLB in the results obtained from the GSEA. We found several clusters of co-expressed genes which we designated by colors in our WGCNA analysis. Furthermore, we identified seven upregulated genes, namely, SNAP25, GRIN2A, GABRG2, GABRA1, GRIA1, SLC17A6, and SYN1, which are significantly correlated with PDD. Conclusion: The seven hub genes and the signaling pathways we identified may be involved in the heterogeneous pathogenesis of PDD and DLB.

Indexed as

biomarkerdementia with Lewy bodieshub geneLewy body dementiasParkinson's disease dementiaweighted gene co-expression network analysis

Identifiers

PMID36970514
PMCPMC10034123
OpenAlexW4323666567

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read11
table measurements read4
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.